Business article - July 9, 2024
Kvantify secures EUR 10 million seed round
The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and the private investment company 2degrees. The investment will accelerate the development of Kvantify’s solutions that aim to leverage quantum computing to address complex problems in drug discovery and beyond. It will also boost the further development of quantum algorithms for […]
Biotech Business - July 8, 2024
Herantis receives funding from The Michael J. Fox Foundation and the Parkinson’s Virtual Biotech
The research funding of EUR 3.6 million will finance Herantis’ Phase 1b clinical trial and expand the on-going biomarker project, it states. “We are proud to be awarded funding for the HER-096 Phase 1b clinical trial from Parkinson’s Virtual Biotech and The Michael J. Fox Foundation, two prestigious organizations in this field. This external validation […]
Business article - July 3, 2024
Commentary: Navigating the Obesity Market
Challenges and Funding Dilemmas from an International and Nordic Perspective. It is no secret that obesity is one of the biggest public health challenges of the 21st century and is one of the leading causes of preventable death globally. It’s estimated that 18% of the global population is obese, with the prevalence of obesity in […]
Financing - June 26, 2024
Novo Nordisk to invest USD 4.1 billion to build a manufacturing facility in USA
Novo Nordisk has announced plans to invest approx DKK 27 billion to build a second fill and finishing manufacturing facility in Clayton, North Carolina, and grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases. Marking one of the largest manufacturing investments in Novo Nordisk’s history, […]
Business - June 25, 2024
HiloProbe secures SEK 3 million in funding
HiloProbe has raised funding from existing owners. “The main focus of this capital injection is to initiate sales, enabling us to attract a larger amount of capital. We anticipate reaching a break-even point after that,” says Lina Olsson, CEO of HiloProbe. HiloProbe describes the interest in its product as “significant” and that the company is close […]
Financing - June 24, 2024
Sound Bioventures invests in US company NephroDI Therapeutics
Sound Bioventures has announced a new investment in NephroDI Therapeutics, a US-based, near-clinical stage pharmaceutical company focusing on concentration disorders of the kidney. In conjunction with this investment, Bibhash Mukhopadhyay, Managing Partner at Sound Bioventures, will join NephroDI’s Board of Directors. “At Sound Bioventures, we aim to back innovative companies working to address some of […]
